LEI 529900ZQU9PJFQ4JOS71
PharmaLex GmbH
Contract awards & public grants
Developing novel inhaled bioengineered Extracellular Vesicle RNA based advanced therapeutics, delivered by tailored aerosol delivery technology for th → PHARMALEX GMBH
European Commission · DE · Grant · 2022-05-24
€602,187
Induced pluripotent stem cell-based therapy for spinal regeneration → PHARMALEX GMBH
European Commission · DE · Grant · 2018-12-07
€676,381
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.